8-K
false00018686400001868640us-gaap:CommonStockMember2023-11-132023-11-130001868640us-gaap:WarrantMember2023-11-132023-11-1300018686402023-11-132023-11-13

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

 

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): November 13, 2023

 

Commission File Number: 001-41094

ROADZEN INC.

(Exact name of registrant as specified in its charter)

 

 

 

 

 

 

British Virgin Islands

98-1600102

(State or Other Jurisdiction of Incorporation or Organization)

(I.R.S. Employer Identification No.)

 

 

 

111 Anza Blvd., Suite 109

Burlingame, California

 

94010

(Address of Principal Executive Offices)

 

(Zip Code)

 

 

Registrant’s telephone number, including area code: (650) 414-3530

 

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencements communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

 

 

 

 

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.0001 per share

 

RDZN

 

The Nasdaq Stock Market LLC

Warrants, each warrant exercisable for one share of common stock, each at an exercise price of $11.50 per share

 

RDZNW

 

The Nasdaq Stock Market LLC

 


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.


 

Item 2.02 Results of Operations and Financial Condition.

On November 13, 2023, Roadzen, Inc. (the “Company”) issued a press release announcing its financial results for the second quarter of fiscal 2024. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The Company refers to non-GAAP financial information in the press release. A reconciliation of these non-GAAP financial measures to the comparable GAAP financial measures is contained in the attached press release.

This information is intended to be furnished under Item 2.02 of Form 8-K, “Results of Operations and Financial Condition” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

 

Exhibit Number

Description of Exhibit

99.1

Press release issued on November 13, 2023

 

 

 


 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: November 13, 2023

 

 

ROADZEN INC.

 

By: /s/ Rohan Malhotra

Name: Rohan Malhotra

Title: Chief Executive Officer

 

 

 


EX-99.1

Exhibit 99.1

https://cdn.kscope.io/bb314cce299a1269e50440eed9fb6716-img27975871_0.jpg 

 

Roadzen Reports Record Revenue for the Second Fiscal Quarter 2024

Revenue Increasing 493% Year-Over-Year to $15.4 Million

Key Highlights:

Roadzen's revenue for the quarter ended September 30, 2023 experienced a substantial increase of $12.8 million over the same quarter of the previous fiscal year.
Growth underscores strong demand for Roadzen’s advanced AI solutions in the $800 billion auto insurance industry.
Revenue composition highlights the strength of Roadzen’s strategic plan with brokerage solutions contributing 54% and enterprise technology sales of the Insurance as a Service (IaaS) platform accounting for 46%.

New York, NY, November 13, 2023 – Roadzen Inc. (Nasdaq: RDZN), a global pioneer in AI-driven insurance and mobility solutions, today reported its first quarterly earnings since becoming a publicly listed entity. The Company's second quarter of its fiscal year 2024 closed with revenue reaching $15.4 million marking a 493% increase from the same quarter last year. Management attributes this growth to strategic acquisitions as well as organic revenue expansion of 89%.

Rohan Malhotra, Co-Founder and CEO of Roadzen, stated, "We are pleased to announce that our first quarter as a public company represents the best revenue quarter in our history, concluding with $15.4 million in revenue and significant year-over-year growth. As AI continues to reshape industry, Roadzen is strategically positioned to become a global leader at the intersection of mobility and insurance."

Malhotra further commented that, "Our revenue growth, fueled by both strategic acquisitions and organic growth, reflects our commitment to delivering innovative solutions within the evolving auto insurance ecosystem. We are focused on bringing onboard new clients, enhancing our embedded distribution model, and employing AI to optimize operations. Roadzen's cutting-edge AI uniquely positions us to be the preferred partner for insurers, fleets and carmakers aiming to innovate their auto insurance offerings."

The Company’s net loss of $31.1 million includes $27.5 million of non-cash, non-recurring and other extraordinary items resulting in an Adjusted EBITDA1 loss of $3.6 million. The Adjusted EBITDA loss of $3.6 million compares to an Adjusted EBITDA loss of $2.3 million in the same quarter of the prior year while growing revenue 493% over the corresponding period.

Market Expansion and Strategic Acquisitions: Roadzen has extended its global reach with strategic acquisitions in the US and UK markets during June 2023. The acquisition of Global Insurance Management Ltd. (GIM), a prominent Managing General Agent specializing in auto insurance, extended warranties and global claims management, solidifies our position in the UK. Similarly, the acquisition of the National Automobile Club (NAC), a California-based entity known for its claims management expertise and round-the-clock commercial roadside assistance, has bolstered our service offerings in the US.

Roadzen partners with 90 enterprise clients that include leading insurers, automakers and large fleets, as well as 3,000 small and medium businesses including agents, brokers, dealerships, and fleets under 100 vehicles.

 

1. Adjusted EBITDA is a non-GAAP financial metrics. See “Non-GAAP Financial Measures” at the end of this press release for more information, including a reconciliation to the nearest GAAP financial measure.

 


 

About Roadzen Inc.

Roadzen Inc. (NASDAQ: RDZN) is a leading insurance technology company on a mission to transform global auto insurance powered by advanced AI. Thousands of clients - from some of the world's leading insurers, fleets, and carmakers to small fleets, brokers, and insurance agents - use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. Roadzen's pioneering work in telematics and computer vision has earned recognition as a top AI innovator by publications such as Forbes, Fortune, and Financial Express. Roadzen has approximately 400 employees across its global offices in the US, India, UK, and France. For more information, visit www.roadzen.io.

Cautionary Statement Regarding Forward-Looking Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” and “continue,” or the negative of such terms or other similar expressions. Such statements include, but are not limited to, statements regarding our strategy, demand for our products, expansion plans, future operations, future operating results, estimated revenues, losses, projected costs, prospects, plans and objectives of management, as well as all other statements other than statements of historical fact included in this press release. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in “Risk Factors” in our Securities and Exchange Commission (“SEC”) filings, including the definitive proxy statement/prospectus we filed with the SEC on August 14, 2023. We urge you to consider these factors, risks and uncertainties carefully in evaluating the forward-looking statements contained in this press release. All subsequent written or oral forward-looking statements attributable to our Company or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. The forward-looking statements included in this press release are made only as of the date of this release. Except as expressly required by applicable securities law, we disclaim any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
 

 


 

Roadzen Inc.

Condensed Consolidated Balance Sheets

(in $, except per share data and share count)

Particulars

 

As of
September 30,
2023
(Unaudited)

 

As of March 31,
2023

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

 

8,109,694

 

 

589,340

 

Accounts receivable, net

 

 

8,687,873

 

 

1,535,985

 

Inventories

 

 

132,641

 

 

59,897

 

Prepayments and other current assets

 

 

34,468,175

 

 

3,181,936

 

Total current assets

 

 

51,398,383

 

 

5,367,158

 

Restricted cash

 

 

886,105

 

 

542,490

 

Non marketable securities

 

 

4,910,030

 

 

4,910,030

 

Property and equipment, net

 

 

305,335

 

 

232,493

 

Goodwill

 

 

2,304,159

 

 

996,441

 

Operating lease right-of-use assets

 

 

918,940

 

 

545,988

 

Intangible assets, net

 

 

4,732,963

 

 

2,469,158

 

Other long term assets

 

 

227,050

 

 

117,484

 

Total assets

 

 

65,682,965

 

 

15,181,242

 

 

 

 

 

 

 

Liabilities, mezzanine equity and stockholders' deficit

 

 

 

 

 

Current liabilities

 

 

 

 

 

Current portion of long-term borrowings

 

 

2,813,526

 

 

2,852,528

 

Short term borrowings

 

 

14,052,206

 

 

4,875,801

 

Due to insurer

 

 

8,175,754

 

 

 

Accounts payable and accrued expenses

 

 

30,584,429

 

 

6,241,066

 

Short-term operating lease liabilities

 

 

455,830

 

 

208,697

 

Other current liabilities

 

 

5,905,161

 

 

2,503,893

 

Total current liabilities

 

 

61,986,906

 

 

16,681,985

 

Long term borrowings

 

 

234,351

 

 

653,269

 

Long-term operating lease liabilities

 

 

272,089

 

 

360,306

 

Other long term liabilities

 

 

954,048

 

 

294,301

 

Total liabilities

 

 

63,447,394

 

 

17,989,861

 

 

 

 

 

 

Commitments and contingencies (refer note 22)

 

 

 

 

 

 

 

 

 

 

Mezzanine equity

 

 

 

 

 

None authorized or issued as on September 30, 2023;Series A and A1 Preferred stock and additional paid in capital, $.0001 par value per share, 81,635,738 shares authorized (Series A 5,442,383 and Series A1 76,193,356); 39,868,173 shares issued and outstanding as on March 31, 2023.

 

 

 

 

48,274,279

 

Stockholders' deficit

 

 

 

 

 

Preference shares, $.0001 par value per share, 60,000,000 shares authorized and none issued as of September 30, 2023 and none authorized or issued as on March 31, 2023

 

 

 

 

 

Common stock and additional paid in capital, $.0001 par value per share, 220,000,000 shares authorized as of September 30 2023 and $.0001 par value per share, 108,840,000 shares authorized as of March 31, 2023 ; 68,440,829 shares and 16,501,984 shares issued and outstanding as of September 30, 2023 and March 31, 2023 respectively

 

 

84,980,325

 

 

303,213

 

Accumulated deficit

 

 

(86,524,231

)

 

(51,448,299

)

Accumulated other comprehensive income/(loss)

 

 

236,448

 

 

(66,903

)

Other components of equity

 

 

3,847,883

 

 

366,786

 

Total stockholders’ deficit

 

 

2,540,425

 

 

(50,845,203

)

Non controlling interest

 

 

(304,854

)

 

(237,695

)

Total deficit

 

 

2,235,571

 

 

(51,082,898

)

Total liabilities, Mezzanine equity and Stockholders’ deficit,
Non controlling interest

 

 

65,682,965

 

 

15,181,242

 

 


 

Roadzen Inc.

Unaudited Condensed Consolidated Statements of Operations

(in $, except per share data and share count)

 

 

 

For the three months ended
September 30,

 

 

For the six months ended
September 30,

 

Particulars

 

2023

 

2022

 

 

2023

 

2022

 

Revenue

 

 

15,470,581

 

 

2,607,577

 

 

 

21,081,491

 

 

5,237,748

 

Costs and expenses:

 

 

 

 

 

 

 

 

 

 

Cost of services (exclusive of depreciation and amortization shown separately)

 

 

6,358,677

 

 

1,351,394

 

 

 

8,848,771

 

 

2,892,065

 

Research and development

 

 

602,105

 

 

638,447

 

 

 

1,175,405

 

 

1,259,911

 

Sales and marketing

 

 

10,059,347

 

 

2,237,701

 

 

 

13,526,403

 

 

4,171,971

 

General and administrative

 

 

5,577,477

 

 

656,198

 

 

 

8,179,460

 

 

1,113,061

 

Depreciation and amortization

 

 

413,315

 

 

369,420

 

 

 

780,853

 

 

772,259

 

Total costs and expenses

 

 

23,010,921

 

 

5,253,160

 

 

 

32,510,892

 

 

10,209,267

 

Loss from operations

 

 

(7,540,340

)

 

(2,645,583

)

 

 

(11,429,401

)

 

(4,971,519

)

Interest income/(expense)

 

 

(617,470

)

 

(150,816

)

 

 

(835,424

)

 

(203,738

)

Fair value gains/(losses) in financial instruments carried at fair value

 

 

(23,590,000

)

 

(4,676,734

)

 

 

(23,590,000

)

 

(5,026,894

)

Other income/(expense) net

 

 

637,492

 

 

8,152

 

 

 

699,922

 

 

117,689

 

Total other income

 

 

(23,569,978

)

 

(4,819,398

)

 

 

(23,725,502

)

 

(5,112,943

)

Loss before income tax expense

 

 

(31,110,318

)

 

(7,464,981

)

 

 

(35,154,903

)

 

(10,084,462

)

Less: Income tax (benefit)/expense

 

 

10,939

 

 

3,447

 

 

 

33,350

 

 

2,008

 

Net Loss

 

 

(31,121,257

)

 

(7,468,428

)

 

 

(35,188,253

)

 

(10,086,470

)

Net loss attributable to non-controlling interest, net of tax

 

 

(39,457

)

 

(39,499

)

 

 

(67,209

)

 

(79,169

)

Net loss attributable to Roadzen Inc.

 

 

(31,081,800

)

 

(7,428,929

)

 

 

(35,121,044

)

 

(10,007,301

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per share attributable to Roadzen Inc. common stockholders

 

 

(31,081,800

)

 

(7,428,929

)

 

 

(35,121,044

)

 

(10,007,301

)

Basic and diluted

 

 

(1.40

)

 

(0.45

)

 

 

(1.81

)

 

(0.61

)

 

 

 

 

 

 

 

 

 

 

 

Weighted-average number of shares outstanding used to compute net loss per share attributable to Roadzen Inc. common stockholders

 

 

22,272,967

 

 

16,501,984

 

 

 

19,387,476

 

 

16,501,984

 

 


 

 


 

Roadzen Inc.

Unaudited Condensed Consolidated Statements of Cash Flow (in $)

 

 

For the six months ended
September 30,

 

Particulars

 

2023

 

2022

 

 

 

 

 

 

 

Cash flows from operating activities

 

 

 

 

 

Net loss including non controlling interest

 

 

(35,188,253

)

 

(10,086,470

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

Depreciation and amortization

 

 

780,853

 

 

772,259

 

Stock based compensation

 

 

3,526,209

 

 

-

 

Deferred income taxes

 

 

79,094

 

 

(89,509

)

Unrealised foreign exchange loss/(profit)

 

 

(28,884

)

 

(4,672

)

Fair value losses in financial instruments carried at fair value

 

 

23,590,000

 

 

5,026,894

 

Expected credit loss allowance

 

 

171,946

 

 

-

 

Lease equalisation reserve

 

 

 

 

(9,715

)

Balances written off/(back)

 

 

(1,609

)

 

 

Changes in assets and liabilities, net of assets acquired and liabilities assumed from acquisitions:

 

 

 

 

 

Inventories

 

 

(73,732

)

 

(9,149

)

Income taxes, net

 

 

19,297

 

 

(47,545

)

Accounts receivables, net

 

 

4,352,472

 

 

169,205

 

Prepayments and other assets

 

 

(30,343,651

)

 

(627,470

)

Accounts payable and accrued expenses and other current liabilities

 

 

19,106,908

 

 

(163,364

)

Other liabilities

 

 

(1,118,459

)

 

412,803

 

Net cash used in operating activities

 

 

(15,127,809

)

 

(4,656,733

)

 

 

 

 

 

 

Cash flows from investing activities

 

 

 

 

 

Purchase of property and equipment, intangible assets and goodwill

 

 

(136,220

)

 

(711,706

)

Acquisition of business

 

 

(5,748,000

)

 

-

 

Net cash used in investing activities

 

 

(5,884,220

)

 

(711,706

)

 

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

 

Proceeds from business combination

 

 

32,770

 

 

-

 

Proceeds from issue of preferred stock

 

 

6,079,409

 

 

-

 

Proceeds from long-term borrowings

 

 

2,805,418

 

 

2,164,728

 

Repayments of long-term borrowings

 

 

(569,207

)

 

(243,406

)

Net proceeds/(payments) from short-term borrowings

 

 

9,218,689

 

 

3,700,604

 

Net cash generated from financing activities

 

 

17,567,079

 

 

5,621,926

 

Effect of exchange rate changes on cash and cash equivalents

 

 

56,372

 

 

(26,055

)

Net (decrease)/increase in cash and cash equivalents (including restricted cash)

 

 

(3,388,578

)

 

227,432

 

Cash acquired in business combination

 

 

11,252,547

 

 

-

 

Cash and cash equivalents at the beginning of the period (including restricted cash)

 

 

1,131,830

 

 

1,086,418

 

Cash and cash equivalents at the end of the period (including restricted cash)

 

 

8,995,799

 

 

1,313,850

 

 

 

 

 

 

 

Reconciliation of cash and cash equivalents

 

 

 

 

 

Cash and cash equivalents

 

 

8,109,694

 

 

1,153,240

 

Restricted cash

 

 

886,105

 

 

160,610

 

Total cash and cash equivalents

 

 

8,995,799

 

 

1,313,850

 

 

 

 

 

 

 

Supplemental disclosure of cash flow information

 

 

 

 

 

Cash paid for interest, net of amounts capitalized

 

 

378,064

 

 

145,061

 

Cash paid for income taxes, net of refunds

 

 

83,680

 

 

133,875

 

Non-cash investing and financing activities

 

 

 

 

 

Convertible preferred stock issued on conversion of convertible notes

 

 

 

 

10,141,462

 

Consideration payable in connection with acquisitions

 

 

1,854,732

 

 

611,204

 

Interest accrued on borrowings

 

 

157,649

 

 

 

 

 


 

Non-GAAP Financial Measures

Adjusted Earnings Before Interest, Tax, Depreciation and Amortization (“Adjusted EBITDA”) is a non-GAAP financial measure which excludes the impact of finance costs, taxes, depreciation and amortization and certain other items from reported net profit or loss. We believe that Adjusted EBITDA aids investors by providing an operating profit/loss without the impact of non-cash depreciation and amortization and certain other items to help clarify sustainability and trends affecting the business. For comparability of reporting, management considers non-GAAP measures in conjunction with U.S. GAAP financial results in evaluating business performance. Adjusted EBITDA should not be considered a substitute for, or superior to, the measures of financial performance prepared in accordance with U.S. GAAP. In addition, Adjusted EBITDA does not purport to represent cash flow provided by, or used for, operating activities in accordance with GAAP and should not be used as a measure of liquidity.

 

The following table reconciles our net loss reported in accordance with U.S. GAAP to Adjusted EBITDA

 

For the three months ended
September 30,

 

Particulars

2023

 

2022

 

Net loss

 

(31,121,257

)

 

(7,468,428

)

Adjusted for:

 

 

 

 

Other (income)/expense net

 

(637,492

)

 

(8,152

)

Interest (income)/expense

 

617,470

 

 

150,816

 

Fair value changes in financial instruments carried at fair value

 

23,590,000

 

 

4,676,734

 

Tax (benefit)/expense

 

10,939

 

 

3,447

 

Depreciation and amortization

 

413,315

 

 

369,420

 

Stock based compensation expense

 

3,526,209

 

 

-

 

Adjusted EBITDA

 

(3,600,816

)

 

(2,276,163

)

 

 

For the six months ended
September 30,

 

Particulars

2023

 

2022

 

Net loss

 

(35,188,253

)

 

(10,086,470

)

Adjusted for:

 

 

 

 

Other (income)/expense net

 

(699,922

)

 

(117,689

)

Interest (income)/expense

 

835,424

 

 

203,738

 

Fair value changes in financial instruments carried at fair value

 

23,590,000

 

 

5,026,894

 

Tax (benefit)/expense

 

33,350

 

 

2,008

 

Depreciation and amortization

 

780,853

 

 

772,259

 

Stock based compensation expense

 

3,526,209

 

 

-

 

Non-recurring expenses

 

1,819,746

 

 

-

 

Adjusted EBITDA

 

(5,302,593

)

 

(4,199,260

)

 


 

For more information, please contact:

Investor Contacts:
Roadzen: Raghav Kansal (
raghav@roadzen.io)
ICR: Michael Bowen & Dhruv Chopra (roadzenIR@icrinc.com)
 

Media Contacts:
Roadzen: Sanya Soni (
sanya@roadzen.io)
ICR: roadzenPR@icrinc.com
Gutenberg: roadzen@thegutenberg.com